Literature DB >> 14671456

Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness.

Gail L Daumit1, Jeanne M Clark, Donald M Steinwachs, Camelia M Graham, Anthony Lehman, Daniel E Ford.   

Abstract

Individuals with severe and persistent mental illness (SPMI) have a preponderance of weight problems, possibly even greater than the obesity epidemic in the general population. Although atypical antipsychotics cause weight gain, their contribution to obesity has not been characterized in a community setting where individuals may take multiple psychotropics associated with weight gain. Using survey information including measured height and weight from a random sample of Maryland Medicaid recipients with SPMI, we compared obesity prevalence to the National Health and Nutrition Examination Survey (NHANES III) sample and a Maryland sample (Behavioral Risk Factor Surveillance System) of the general population adjusted to SPMI demographic characteristics. We investigated correlates of obesity in the SPMI sample. The results indicate that both men and especially women with SPMI had a higher prevalence of obesity than the general population; this portends substantial health implications. A fourfold association between atypical antipsychotics and prevalent obesity was found in men but not in women; further work should clarify mechanisms of obesity in the SPMI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671456     DOI: 10.1097/01.nmd.0000100923.20188.2d

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  41 in total

1.  Injury risk and severity in a sample of Maryland residents with serious mental illness.

Authors:  Emma E McGinty; Susan P Baker; Donald M Steinwachs; Gail Daumit
Journal:  Inj Prev       Date:  2012-06-02       Impact factor: 2.399

2.  Patients with Schizophrenia Do Not Demonstrate Worse Outcome After Sleeve Gastrectomy: a Short-Term Cohort Study.

Authors:  Rami Archid; Nicole Archid; Tobias Meile; Jonas Hoffmann; Julia Hilbert; Daniel Wulff; Martin Teufel; Michaela Muthig; Markus Quante; Alfred Königsrainer; Jessica Lange
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

Review 3.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Gender differences in antipsychotics prescribed to veterans with serious mental illness.

Authors:  Elana Schwartz; Melanie Charlotte; Eric Slade; Deborah Medoff; Lan Li; Lisa Dixon; Amy Kilbourne; Julie Kreyenbuhl
Journal:  Gen Hosp Psychiatry       Date:  2015-04-01       Impact factor: 3.238

5.  Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: A qualitative study.

Authors:  Roza Vazin; Emma E McGinty; Faith Dickerson; Arlene Dalcin; Stacy Goldsholl; Meghan Oefinger Enriquez; Gerald J Jerome; Joseph V Gennusa; Gail L Daumit
Journal:  Psychiatr Rehabil J       Date:  2016-04-07

6.  Perceptions and dietary intake of self-described healthy and unhealthy eaters with severe mental illness.

Authors:  Nancy E Carson; Christine E Blake; Ruth Saunders
Journal:  Community Ment Health J       Date:  2014-12-23

7.  Implementation of a weight loss program for Latino outpatients with severe mental illness.

Authors:  Christina Mangurian; Simriti Chaudhry; Lucia Capitelli; Jonathan Amiel; Felicia Rosario; Carlos Jackson; John W Newcomer; Francine Cournos; Susan Essock; Diane Barrett; Michael Devlin
Journal:  Community Ment Health J       Date:  2012-03-24

8.  Lifestyle Intervention for People With Severe Obesity and Serious Mental Illness.

Authors:  John A Naslund; Kelly A Aschbrenner; Emily A Scherer; Sarah I Pratt; Rosemarie S Wolfe; Stephen J Bartels
Journal:  Am J Prev Med       Date:  2015-09-16       Impact factor: 5.043

9.  Psychological conditions in adults with diabetes.

Authors:  Mary de Groot; Sherita Hill Golden; Julie Wagner
Journal:  Am Psychol       Date:  2016-10

10.  Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes.

Authors:  Julie Kreyenbuhl; Deborah R Medoff; Stephen L Seliger; Lisa B Dixon
Journal:  Schizophr Res       Date:  2008-03-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.